These studies revealed adverse developmental outcomes, including fetal growth abnormalities and skeletal malformations, when administered during organogenesis at clinically relevant exposures
10.2337/dc21-S009 3 AstrupA.RssnerS.Van GaalL.RissanenA.NiskanenL.Al HakimM.et al (2009)
Most major insurers including Blue Cross Blue Shield of Mississippi, Humana, and Aetna may cover physician consultations and medical evaluations, but coverage for weight loss medications like GLP-1 drugs depends on specific policy details and medical necessity criteria
Salen-based metallocompounds are protective in animal models of heart-ischemiareperfusion, amyotrophic lateral sclerosis, stroke, radiation-related lung fibrosis, and other diseases
10mg total lyophilized powder, 99%+ purity verified by Janoshik Analytical via HPLC and mass spectrometry